Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

09:09 EDT 27th August 2014 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 7,900+

Monday 25th August 2014

Advanced Catheter Therapies brings in $4.5mm via Series B

Cardiovascular device developer Advanced Catheter Therapies Inc. raised $4.5mm in an oversubscribed Series B financing of preferred shares to returning shareholders ACT I Investments, Chattanooga Renaissance Fund, and the Maclellan Foundation, along...

Civitas Therapeutics Secures $55 Million in Series C Financing

Proceeds to support Phase 3 clinical trials for CVT-301 Parkinson’s disease program and pipeline expansion Civitas Therapeutics, Inc., a privately-held biopharmaceutical company developing and commercializing transformative therapeutics using its proprietary ARCUSTM technology, today announced the successful completion of a $55 million Series C finan...

Civitas secures $55 million in series C

Civitas Therapeutics Inc. (Chelsea, Mass.) secured $55 million in a series C round from new investors Adage Capital Management; OrbiMed Advisors; Partner Fund Management; Rock Springs Capital; and Sofinnova Ventures. All of Civitas' existing investor...

Aldea closes $24 million B round

Aldea Pharmaceuticals Inc. (Redwood City, Calif.) closed a $24 million series B round led by new investor RusnanoMedInvest. New investor WuXi PharmaTech Corporate Venture also participated, along with all of Aldea's existing investors, including Cana...

Canadian marijuana firms OrganiGram, Bedrocan soar on market debut

TORONTO, Aug 25 (Reuters) - Shares of Canadian medical marijuana producers Bedrocan Cannabis Corp and OrganiGram Holdings Inc jumped as they began trading on the TSX Venture exchange on Monday with investors expecting fast-growing demand in the fledg...

Stifel, Janney start Marinus Pharma at buy

Stifel and Janney Capital Markets have launched coverage of Marinus Pharmaceuticals (NASDAQ:MRNS) with a “buy” ratings. “In our opinion, [Marinus’] ganaxolone represents a compelling, differentiated treatment for epilepsy with a novel mechanism that will help it stand apart,” writes Stifel analyst Dr. Brian Klein. He set an $11 price target on the stock, which closed […]

Australia Gynecological Devices Market Analysis & Forecast to 2020 in a New Report Available at MarketOptimizer.org

MarketOptimizer.org adds “Australia Gynecological Devices Market Outlook to 2020” to its store. The data in the report is derived from dynamic market forecast models. Dallas, TX (PRWEB) August 25, 2014 Australia Gynecological Devices Market Outlook to 2020 provides key market data on the Australia Gynecological Devices market. The report provides value, in millions of US dollars, volume (in u...

Roth starts BioBlast Pharma at buy

Roth Capital Partners has initiated coverage of BioBlast Pharma (NASDAQ:ORPN) with a “buy” rating and $15 price target. The stock closed at $7.68 on Friday. BioBlast has three proprietary platform technologies to treat rare and ultra-rare genetic diseases. They include Cabaletta for mutant protein stabilization, BBrm for induction of read-through (bypass) of early mutant DNA stop codons, [&#...

Jack Jewett Named Arizona Bioscience Leader of the Year

Jack B. Jewett, President & CEO of the Flinn Foundation, will be honored with the Jon W. McGarity Arizona Bioscience Leader of the Year Award by the Arizona BioIndustry Association. “Great leaders embrace possibilities and take the steps to make them reality. Jack B. Jewett has done more than just take steps,” shared Joan Koerber-Walker,...

Viropro Initiates Interim Debt Financing of Up to $500,000

SAN JOSE, Calif., Aug. 25, 2014 /PRNewswire/ -- Viropro, Inc. today announced that it has entered into a definitive agreement with Spring Hill Bioventures outlining the terms through which the company will raise up to $500,000 in convertible debt.  Simultaneously, Spring Hill has closed on an initial commitment of $200,000. The proceeds of the financing will be used for the preparation of au...

Hercules Issues Additional $3 Million in Principal of 6.25% Notes Due 2024 to Cover Underwriters Over-Allotment Option

Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (the “Company), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology industries, today announced that in connection with...

Ebola Vaccine Using Immunovaccine's DepoVax Proves Highly Efficacious in Non-Human Primate Study / All Vaccinated Animals Given a Lethal Dose of the Ebola Virus Survive

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 08/25/14 -- Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE: IMV), a clinical stage vaccine company, today announced positive results for a vaccine formu...

3M Invests In Toronto-based Smart Energy Instruments

MAPLEWOOD (dpa-AFX) - 3M New Ventures, the corporate venture arm of diversified manufacturer 3M Company (MMM) Monday announced an equity stake in Toronto-based Smart Energy Instruments, or SEI, a ...

Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS™ In Argentina

NASDAQ: CRME   TSX: COM VANCOUVER, Aug. 25, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that its subsidiary, Correvio International Sàrl, has entered into an agreement with Eurolab Especialidades Medicinales de Eurofar S.R.L. to sell and distribute BRINAVESS™ (vernakalant intravenous) exclusively in Argentina. Under the terms of...

Johnson & Johnson: High Profitability, Trading Below Fair Value

By Jonathan Weber:Johnson & Johnson (NYSE:JNJ) is one of the biggest healthcare companies in the world, with revenues of $74 billion and earnings of $15.6 billion in the last twelve months. Right now the company has a market capitalization of $291 billion.The company operates in three divisions:- pharmaceutical (40% of sales in 2013)- medical devices and diagnostics (40% of sales in 2013)- con...

Safran's CFM unit scores $2 bln engine order

PARIS, Aug 25 (Reuters) - French aerospace group Safran said on Monday that BOC Aviation had placed an engine order worth an estimated $2 billion with CFM International, a joint-venture between Safran and General Electric.

3M Invests in Smart Energy Instruments

Stake will bolster 3M's relevance in energy market 3M New Ventures the corporate venture arm of 3M announced an equity stake in Toronto-based Smart Energy Instruments (SEI), a move that will furth...

Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk

MARLBOROUGH, Mass., Aug. 25, 2014 /PRNewswire/ -- Lemelson Capital Management, a private investment management firm, today released additional research and comments on Ligand Pharmaceuticals (NASDAQ: LGND) amidst the company's unusual and complex debt arrangement under which the firm has assumed $245 million in debt principally so that large institutional shareholders can offload shares of th...

FortuneRock (China) Ltd. Announces Investments Totaling $24 Million

FortuneRock (China) Ltd. is pleased to announce that it has received investments for its ongoing novel protein drug development and pre-IPO funding totaling $24m (RMB145m). About RMB120m is to support the set up of a new spin-off enterprise including building a new GMP manufacturing facility in Tianjin and about RMB25m is to assist the Company with develop...

Monday's most followed in U.S. including Burger King, Tim Hortons, Ann, InterMune, Regado, BlackBerry, Sonoco, Goldman Sachs, U.S. Steel

U.S. shares advanced on signs of more corporate takeovers and stimulus for the European economy. The S&P 500 (INDEXSP:.INX) gained 0.7 percent at 11:31 a.m. in New York. The 30-company Dow Jones Industrial Average (INDEXDJX:.DJI) rose 0.7 percent...

Cannabis Science, Inc. (CBIS) In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada

COLORADO SPRINGS, Colo., Aug. 25, 2014 /PRNewswire/ -- Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce that it is in the final stages of negotiations for the acquisition of a company that has applied for a "Marihuana for Medical Purposes" (Canada) license with Health Canada....

Truveris Launches RxDash, a Game-Changer that Allows Instant Price and Plan Design Modeling for Pharmacy Benefits Changes

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Truveris, a premier pharmacy benefit pricing and analytics company, today announced the launch of RxDashSM, an enterprise platform for pharmacy plan repricing, modeling and reporting. A cutting-edge Software-as-a-Service (SaaS) solution, RxDash enables pharmacy benefit managers (PBMs), health insurers, consulting companies and plan administrators to view in...

Northeastern Nevada Radiation Oncology Center to be Built in Elko, Nevada

ELKO, Nev., Aug. 25, 2014 /PRNewswire/ -- Dr. Douglas Debenham, board certified radiation oncologist, has announced plans to build a new radiation oncology center in Elko, Nevada this year.  The new Northeastern Nevada Radiation Oncology Center will be fully operational and treating patients by the first quarter of 2015, thanks to a partnership between RBS Evolution (RBSE), a provid...

Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner

CAMBRIDGE, Mass., Aug. 25, 2014 /PRNewswire/ -- Flagship Ventures, a leading venture capital and venture creation firm focused on innovations in healthcare and sustainability, today announced the appointment of Dr. Robert Berendes as a Venture Partner. Dr. Berendes, who most recently was a member of the executive team at Syngenta, will provide strategic counsel and support to the Flagship team. Th...

Abbott Commences Tender Offer for All Outstanding Ordinary Shares and American Depositary Shares of CFR Pharmaceuticals S.A.

ABBOTT PARK, Ill., Aug. 25, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Offer"), in which it is offering to purchase (i) from U.S. holders only, up to 100 percent of the outstanding ordinary, nominative, no par value shares (th...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks